UK to collect COVID-19 survivors' blood for treatment trials
To investigate if convalescent plasma transfusions could improve speed of recovery and chances of survival
PHOTO: REUTERS
LONDON:
The United Kingdom is preparing to collect the blood from COVID-19 survivors to investigate if convalescent plasma transfusions could improve a COVID-19 patient’s speed of recovery and chances of survival.
“NHS Blood and Transplant is preparing to collect COVID-19 convalescent plasma from people who have recovered from this illness,” a spokesperson said. “We envisage that this will be initially used in trials as a possible treatment for COVID-19.”
“If fully approved, the trials will investigate whether convalescent plasma transfusions could improve a COVID-19 patient’s speed of recovery and chances of survival,” the blood service said.
“We are working closely with the government and all relevant bodies to move through the approvals process as quickly as possible,” it said.
The United Kingdom is preparing to collect the blood from COVID-19 survivors to investigate if convalescent plasma transfusions could improve a COVID-19 patient’s speed of recovery and chances of survival.
“NHS Blood and Transplant is preparing to collect COVID-19 convalescent plasma from people who have recovered from this illness,” a spokesperson said. “We envisage that this will be initially used in trials as a possible treatment for COVID-19.”
“If fully approved, the trials will investigate whether convalescent plasma transfusions could improve a COVID-19 patient’s speed of recovery and chances of survival,” the blood service said.
“We are working closely with the government and all relevant bodies to move through the approvals process as quickly as possible,” it said.